CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in three upcoming investor conferences.
- March 7th, 2017 at 8:00 a.m. ET, SeaSpine's management is scheduled to present at the Cowen & Company 37th Annual Healthcare Conference in Boston, MA
- March 14th, 2017 at 9:30 a.m. PT, SeaSpine's management is scheduled to present at the Canaccord Genuity 2017 Musculoskeletal Conference San Diego, CA
- March 21st, 2017 at 10:20 a.m. ET, SeaSpine's management is scheduled to present at the Oppenheimer 27th Annual Healthcare Conference in New York City, NY
Interested parties can access the live audio webcast at http://www.seaspine.com.
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development helps SeaSpine to offer its surgeon customers a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.